3 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

TMC the metals company

The Trade: TMC the metals company Inc. TMC Director Andrei Karkar, Eras Capital Llc bought a total of 2250110 shares at an average price of $4.44. To acquire these shares, it cost $9,999,938.86.

What’s Happening: The company’s shares jumped more than 25% over the previous month.

What TMC the metals company Does: TMC The Metals Co is an explorer of lower-impact battery metals from seafloor polymetallic nodules.

Reed's

The Trade: Reed's, Inc. REED CEO Norman E. Snyder Jr. acquired a total of 50000 shares shares at an average price of $0.59. The insider spent $29,500.00 to buy those shares.

What’s Happening: Reed's, in August, reported worse-than-expected Q2 sales results.

What Reed's Does: Reed's sells Ginger Beer brand. The company's portfolio of handcrafted, all-natural beverages sold in over 40,000 outlets nationwide including the natural and specialty food channel, grocery stores, mass merchants,

Cumberland Pharmaceuticals

The Trade: Cumberland Pharmaceuticals Inc. CPIX Director Kenneth Krogulski acquired a total of 1785 shares at an average price of $2.83. To acquire these shares, it cost $5,049.85.

What’s Happening: Cumberland Pharmaceuticals announced the launch of RediTrex product line for active rheumatoid, juvenile idiopathic and severe psoriatic arthritis.

What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals is a specialty pharmaceutical company operating in the United States.